Effect of postoperative xylazine administration on cardiopulmonary function and recovery quality after isoflurane anesthesia in horses.
Authors: Ida Keila K, Fantoni Denise T, Ibiapina Bruna T, Souto Maria-Teresa M R, Zoppa André L V, Silva Luis Claudio L C, Ambrósio Aline M
Journal: Veterinary surgery : VS
Summary
# Editorial Summary Sedation during recovery from general anaesthesia is common practice in equine surgery, yet optimal dosing strategies remain unclear. This randomised, blinded clinical trial compared two intravenous xylazine doses (0.25 mg/kg versus 0.50 mg/kg) administered to 20 horses recovering from three hours of isoflurane anaesthesia for arthroscopic procedures, measuring cardiopulmonary variables, arterial blood gases, and recovery quality over 45 minutes post-injection and 30 minutes after standing. The lower dose (0.25 mg/kg) produced significantly faster standing times (33 versus 50 minutes; P < 0.0001) but paradoxically inferior recovery scores, whereas the higher dose (0.50 mg/kg) achieved better-quality recoveries with fewer attempts to stand (1±1 versus 4±2 attempts; P < 0.001), though both doses induced moderate transient hypoxaemia with comparable nadir arterial oxygen tensions (54–55 mmHg occurring at 10–20 minutes). For practitioners, these findings suggest that whilst accelerated recovery times might appear clinically desirable, the 0.50 mg/kg dose's superior recovery quality and reduced struggling behaviour likely represent safer, more controllable emergence—particularly valuable for minimising injury risk and stress in horses, despite accepting a longer recovery window and monitoring hypoxaemia that appears self-limiting in both protocols.
Read the full abstract on PubMed
Practical Takeaways
- •If minimizing recovery time is priority, use 0.25 mg/kg xylazine; if smoother, safer recovery with fewer falls is needed, use 0.50 mg/kg despite longer duration
- •Expect transient hypoxemia during recovery with either dose—monitor oxygenation and have supplemental oxygen available
- •The 0.50 mg/kg dose reduces dangerous standing attempts (fewer falls), making it preferable for most clinical situations despite 17 minutes longer recovery
Key Findings
- •0.25 mg/kg xylazine resulted in faster recovery (33±5 min) compared to 0.50 mg/kg (50±7 min, P<0.0001)
- •Both doses caused moderate transient hypoxemia with arterial oxygen tension decreases of 54-55 mmHg
- •0.50 mg/kg xylazine produced better recovery quality scores (18 vs 23, P<0.001) and fewer standing attempts (1±1 vs 4±2, P<0.001)
- •Higher xylazine dose improved recovery quality despite prolonging recovery time